PUBLISHER: 360iResearch | PRODUCT CODE: 1492605
PUBLISHER: 360iResearch | PRODUCT CODE: 1492605
[186 Pages Report] The Equine Healthcare Market size was estimated at USD 3.25 billion in 2023 and expected to reach USD 3.46 billion in 2024, at a CAGR 6.52% to reach USD 5.07 billion by 2030.
Equine healthcare encompasses a broad range of services, practices, and products aimed at maintaining and enhancing the health and well-being of horses. This specialized field of veterinary medicine includes preventive care, diagnosis, treatment, and management of illnesses, injuries, and disorders specific to horses. The critical components of equine healthcare involve routine vaccinations, dental care, nutritional management, parasite control, and emergency medical services. Equine healthcare includes using advanced diagnostic tools, surgical procedures, physiotherapy, and rehabilitation for equines. With a focus on preventive measures and therapeutic interventions, equine healthcare is crucial in ensuring horses' longevity, performance, and quality of life. The growth of the equine healthcare market is driven by the rising popularity of equine sports, increased horse ownership for leisure and companionship, and a growing awareness of animal health and welfare. However, stringent regulatory requirements for drug approval act as a challenge to expanding the equine healthcare market. Personalized medicine based on genetic insights and the incorporation of telemedicine for remote diagnostics and treatment is vital for research and development areas to sustain equine healthcare market growth and address future demands.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.25 billion |
Estimated Year [2024] | USD 3.46 billion |
Forecast Year [2030] | USD 5.07 billion |
CAGR (%) | 6.52% |
Regional Insights
In the Americas, the U.S. has a substantial equine population and a prevalent horse racing culture, investing heavily in healthcare services, focusing on disease prevention, treatment, and welfare. The U.S. showcases innovations in equine health, demonstrated by the latest patents in gene therapy and digital health monitoring systems designed for early disease detection and prevention. Canada has implemented stringent regulatory standards that govern the care and treatment of equines, ensuring they receive the highest level of healthcare. These regulations cover a wide range of practices, from disease prevention and control to the humane treatment of animals. The increasing urbanization, disposable income, and a growing interest in equestrian sports have significantly contributed to expanding the equine healthcare market in the Asia Pacific region. In China, the focus remains on improving breeding methods and disease management, backed by governmental support and private investments. Japan's well-established racing industry propels the need for advanced healthcare and therapeutics. The equine healthcare sector in India is benefitting from initiatives aimed at improving breed quality and veterinary care infrastructure, contributing to the market's overall growth. The EMEA region presents a diverse picture, with EU countries traditionally strongholds in equestrian sports and, thus, equine healthcare. In the EMEA region, the equine healthcare market is driven by several factors, including the increasing popularity of horse racing, sports, and leisure activities involving horses, which necessitate regular health check-ups and maintenance. Advanced reproductive technologies and preventive equine healthcare are gaining traction in the Middle East. The Middle East invests heavily in equine welfare, breeding, and healthcare, and the advanced facilities in countries such as the United Arab Emirates epitomize the high standard of care provided. Genetic research and preservation of bloodlines are significant, with substantial funding allocated to safeguarding the heritage and performance of Arabian equines. In the African region, particularly in South Africa, the adoption of equine healthcare is propelled by the growing horse racing community and enthusiasm for equine sports.
Market Insights
The market dynamics represent an ever-changing landscape of the Equine Healthcare Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Equine Healthcare Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Equine Healthcare Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Neogen Announced Biosecurity Partnership with TerraNova
Neogen Corporation announced a partnership with TerraNova. The partnership is poised to leverage TerraNova's innovative biosecurity solutions alongside Neogen's extensive repertoire of animal safety products, aiming to significantly elevate hygiene and disease prevention standards in equine environments. Neogen and TerraNova are dedicated to delivering unparalleled expertise and solutions through the partnership, addressing the pressing need for holistic and effective biosecurity practices in the realm of equine healthcare. [Published On: 2023-12-05]
Hilltop Bio Launched Strydaflex for Equine Joints
Hilltop Bio announced the launch of StrydaFlex, an advanced therapy explicitly designed for equine healthcare. The novel product addresses a wide range of significant health concerns that are prevalent among horses, including joint issues and inflammation, by harnessing advanced biotechnology methods. [Published On: 2023-04-25]
Covetrus Launches SmartImmune Mushroom to Help Support Powerful Immune Defense in Horses
Covetrus introduced SmartImmune Mushroom, an innovative product designed to bolster the immune defenses of horses. The latest addition to Covetrus's portfolio is the culmination of extensive research into equine health needs. SmartImmune Mushroom leverages the natural immune-supporting properties of mushrooms, offering a powerful yet holistic approach to enhance equine well-being. [Published On: 2023-04-05]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Equine Healthcare Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Equine Healthcare Market, highlighting leading vendors and their innovative profiles. These include Alltech Inc., Archer-Daniels-Midland Company, Bayer AG, Belvoir Equine Limited, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Covetrus, Inc., Dechra Pharmaceuticals PLC, ELANCO ANIMAL HEALTH INCORPORATED, ESAOTE SPA, Hallmarq Veterinary Imaging Inc., Hilltop Biosciences, IDEXX Laboratories, Inc., Kent Nutrition Group, Land O'Lakes, Inc., Merck & Co., Inc., Mg Biologics, Neogen Corporation, Platinum Performance, Inc., Sanofi S.A., Vetoquinol S.A., W.F. Young, Inc., and Zoetis Inc..
Market Segmentation & Coverage